.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Baxter
QuintilesIMS
Mallinckrodt
Teva
Queensland Health
Covington
US Army
US Department of Justice
Moodys

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,078,054

« Back to Dashboard

Details for Patent: 7,078,054

Title:Soft gelatin capsule manufacture
Abstract: Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the capsule filling and in the capsule shell. The manufacture of said capsules is improved, if in the process for making the soft gelatin capsules the gelatin bands are cooled with a liquid, and preferably with water.
Inventor(s): Brox; Werner (Beerfelden, DE), Meinzer; Armin (Freiburg, DE), Zande; Horst (Schonbrunn, DE)
Assignee: Novartis AG (Basel, CH)
Filing Date:May 13, 2003
Application Number:10/437,098
Claims:1. A liquid filled soft gelatin capsule characterized in that the capsule shell contains a migrateable component which is also present in the capsule filling wherein the migrateable component is selected from the group consisting of tetrahydrofurylalcohol ether, diethylene glycol mono ethylether, 1,3-dimethyl-2-imidazolidinone, dimethylisosorbide or propylene glycol.

2. A soft gelatin capsule according to claim 1, characterized in that the migrateable component is capable of mixing with, or forming a solution with, the gelatin.

3. A soft gelatin capsule according to claim 1 wherein the migrateable component is 1,2-propyleneglycol.

4. A soft gelatin capsule of claim 1 having a capsule shell comprising gelatin, plasticizers, 1,2-propyleneglycol and, optionally further auxiliary agents, and a capsule filling containing a solvent, wherein the solvent is at least partially 1,2-propyleneglycol, but not predominantly 1,2-propyleneglycol.

5. A soft gelatin capsule according to claim 1 characterized in that the capsule filling contains a lipophilic component.

6. A soft gelatin capsule according to claim 1 characterized in that the capsule filling contains a surfactant.

7. A soft gelatin capsule according to claim 1 characterized in that the capsule filling is capable of forming an emulsion on mixing with water.

8. A soft gelatin capsule according to claim 1 characterized in that the capsule filling is in the form of a microemulsion pre-concentrate which contains 1,2-propyleneglycol as a hydrophilic and migrateable component.

9. A soft gelatin capsule according to claim 1 characterized in that the capsule shell contains at least 5% of migrateable component.

10. A soft gelatin capsule according to claim 1, characterized in that the capsule shell contains from 5 to 40% of migrateable component.

11. A soft gelatin capsule according to claim 1, characterized in that the capsule filling contains ethanol.

12. A soft gelatin capsule according to claim 1, characterized in that the capsule shell contains up to 32% of migrateable component.

13. A soft gelatin capsule according to claim 1 further comprising a pharmacologically active substance which has a solubility in water of less than 1%.

14. A soft gelatin capsule according to claim 13 wherein the pharmacologically active substance is a cyclosporin or macrolide.

15. A soft gelatin capsule according to claim 14 wherein the pharmacologically active substance is cyclosporin A or G.

16. In a Rotary Die Process for encapsulating a liquid mixture in gelatin to form soft gelatin capsules, wherein one component of the mixture has a propensity to migrate into gelatin, the improvement comprising encapsulating the mixture with a shell comprising the same migrateable component, wherein said migrateable component is other than glycerol and polyethylene glycol.

17. In a Rotary Die Process for manufacturing soft gelatin capsules having a capsule shell comprising gelatin and a component which leads to tackiness, the improvement comprising cooling of the gelatin bands used to form the capsule shell using a liquid coolant.

18. A process according to claim 17 wherein the capsule shell further comprises plasticizers, 1,2-propyleneglycol and, optionally further auxiliary agents, and a capsule filling containing a solvent, wherein the solvent at least partially is 1,2-propyleneglycol.

19. The process according to claim 17 or 18 wherein the liquid coolant is water.

20. An improved apparatus for use in a Rotary Die Process of manufacturing soft gelatin capsules in which a cooling drum is used for cooling gelatin bands which form the gelatin capsule shells wherein the improvement comprises the drum having means for cooling the drum surface using a liquid coolant.

21. The cooling drum of claim 20 wherein the liquid coolant is water.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Express Scripts
Merck
Teva
Chinese Patent Office
Daiichi Sankyo
Accenture
Cipla
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot